ArticleClinical hypertension2025
Impact of home and clinical blood pressure variability on arteriosclerosis and metabolic indicators: a prospective multicenter registry study.
Article in Clinical hypertension, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06394934 (Impact of Home and Clinical Blood Pressure Variability on Arteriosclerosis and Metabolic Indicators), which is not on this map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Impact of Home and Clinical Blood Pressure Variability on Arteriosclerosis and Metabolic Indicators
Who cites it
1 citing paper in PubMed.
- To be (IIb), or not to be (IIb) - That is the current status of cuffless blood pressure monitoring device.Clinical hypertension · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Blood pressure variability (BPV) represents an independent predictor of cardiovascular disease, distinct from mean blood pressure (BP). While home BP monitoring is widely recommended, the associations between home BPV and vascular, metabolic, and inflammatory markers remain unclear. We aimed to clarify these associations. Methods: We analyzed 519 hypertensive patients from a prospective multicenter registry. Home BPV was assessed using standard deviation, coefficient of variation (CV), average real variability, variability independent of the mean, and range. Patients were stratified by the median CV of home systolic BP (SBP). We used Pearson correlation coefficients to evaluate the relationships between home BPV and office BPV, metabolic parameters, and arterial stiffness indices. Results: Based on stratification by the CV of home SBP, the high-BPV group was characterized by older age, a greater proportion of women, and a lower body mass index compared with the low-BPV group. Correlations between home and office BP were stronger for mean values than for variability indices. Home systolic BPV indices correlated positively with high-sensitivity C-reactive protein ( Conclusions: Home systolic BPV showed consistent associations with vascular inflammation and arterial stiffness, but not with metabolic parameters. These findings support home BPV as a distinct cardiovascular risk marker with potential relevance for risk stratification and preventive management. Trial Registration: ClinicalTrials.gov Identifier: NCT06394934.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.